Polygenic profiles define aspects of clinical heterogeneity in ADHD
Sonja LaBianca(Mental Health Services), Andrew J. Schork(University of California, San Diego), Søren Dalsgaard(Lundbeck Foundation), Ole Mors(Aarhus University), Preben Bo Mortensen(Aarhus University), Isabell Brikell(Aarhus University), Daniel H. Geschwind(University of California, Los Angeles), Anders D. Børglum(Aarhus University), Rebecca L. Walker(Broad Institute), Dorte Helenius(Mental Health Services), Merete Nordentoft(University of Copenhagen), Robert Loughnan(University of California San Diego), Joel Mefford(University of California, Los Angeles), Thomas Werge(Sankt Hans Hospital), Esben Agerbo(Lundbeck Foundation), Jesper R. Gådin(Mental Health Services), Andrew Dahl(University of Chicago), Terry L. Jernigan(University of California, San Diego), Noah Zaitlen(University of California, San Francisco), Morten Dybdahl Krebs(Mental Health Services), Morteza Vaez(Mental Health Services), Vivek Appadurai(Mental Health Services), David M. Hougaard(Statens Serum Institut), Andrés Ingason(deCODE Genetics (Iceland)), Kenneth S. Kendler(Virginia Commonwealth University), Marianne G. Pedersen(Aarhus University), Clare E. Palmer(University of California San Diego)
Cited by 5
Related Papers
Identification of common genetic risk variants for autism spectrum disorder
|Nature Genetics|2019|2.6k
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder
|Nature Genetics|2018|2.3k
The Basics of Brain Development
|Neuropsychology Review|2010|2k
How mental health care should change as a consequence of the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.9k
Large recurrent microdeletions associated with schizophrenia
|Nature|2008|1.8k